New biomedical technologies are on the cusp of dramatically impacting not only healthcare and how we treat disease, but life itself. Visionary biologist, Andrew Hessel, spoke at our May What’s Now: San Francisco session exploring the extraordinary potential—and potential drawbacks—of gene editing and 3D printing in the field of biotech.
Related Resources
Managing the Content eXplosion
Creating and delivering relevant and timely content to drive meaningful engagement and...
Universal Banking
Capgemini’s Universal Banking Solution unifies customer interactions across the bank’s lines...